MET and cancer: Mutant p53 was proposed to promote enhanced receptor recycling of c-MET and ITGα5 to the cell surface in mutant p53 cancers, leading to increased cell surface protein expression, downstream signaling and effector functions of enhanced scattering and invasion [24,25].